Katherine Riddle
Acute Care · Southgate, MINPI 1336922244
Payments from drug & device makers
Across 73 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$336
- AbbVie$220
- SK Life Science, Inc.$127
- AstraZeneca$107
- Neurocrine Biosciences, Inc.$93
- EMD Serono, Inc.$91
- plus $426 from 11 others
What the payments were for
- Food & beverage$1,401100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 25 | $336 |
| AbbVie | 10 | $220 |
| SK Life Science, Inc. | 5 | $127 |
| AstraZeneca(2 entities) | 6 | $107 |
| Neurocrine Biosciences, Inc. | 3 | $93 |
| EMD Serono, Inc. | 3 | $91 |
| Scilex Pharmaceuticals Inc. | 3 | $73 |
| UCB, Inc. | 3 | $66 |
| Argenx US, Inc. | 3 | $62 |
| Pfizer | 3 | $48 |
| Genentech USA, Inc. | 2 | $46 |
| Neurelis, Inc. | 2 | $33 |
| Boston Scientific | 1 | $26 |
| Eisai Inc. | 1 | $23 |
| Biogen | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
How this compares
$1,401 in reported general payments places this provider in the 80th percentile of 567 acute care providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 332 | $3,020 |
| Pregabalin | 105 | $2,410 |
| Lidocaine | 23 | $1,731 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 151 | $1,543 |
| Duloxetine Hcl | 32 | $1,191 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 24 | $995 |
| Naloxone Hcl | 12 | $913 |
| Celecoxib | 33 | $867 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 51 | $596 |
| Etodolac | 13 | $567 |
| Diclofenac Sodium | 25 | $527 |
| Levetiracetam | 25 | $527 |
| Tizanidine Hcl | 54 | $475 |
| Primidone | 11 | $428 |
| Donepezil Hcl | 24 | $278 |
Paid to pharmacies, not to this prescriber.
Other acute care in Southgate
- Janet WymanDetroit$103K
- Stephanie Mellon ReppenDetroit$57K
- Ashley WozniakLivonia$26K
- Julia BriggsBirch Run$16K
- Candise LovePort Huron$14K
- Janette GuertinPort Huron$14K
- Gregory AliNovi$13K
- Andrew PalmerLansing$9K
- Angela BrennanDearborn Heights$7K
- Jennifer RutzenLansing$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.